NPNadin Piekarek

Nadin Piekarek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadin Piekarek has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Regulation of Vascular Tone of Preglomerular Renal Vasculature by Caldesmon

    by Galyna Pryymachuk, Viktor V. Velyanov, Nikola R. Lazarov, Simon Nestele, Mechthild M. Schroeter, Sarah Jelinek, Nadin Piekarek, Maria Bust, Nikolai T. Evtimov, Simeon P. Marinov, et al.

    Background: Caldesmon is an actomyosin‐tropomyosin–binding protein with pleiotropic functions that generally acts as an inhibitor of actomyosin ATPase activity. This study aims to explore the role of caldesmon in regulation of preglomerular vascular tone. Methods: Expression of caldesmon , myosin light chain, and α‐smooth muscle actin was assessed by western blot of interlobar arteries (IAs) from young and old mice or human renal arteries from patients who underwent nephrectomy or tumor enucleation. IAs were obtained from wild‐type or heterozygous mice, carrying a mutant allele that ablates both caldesmon isoforms ( caldesmon +/− ). In IAs , the vasoreactivity to α 1 ‐agonist phenylephrine, the soluble guanylate cyclase activator cinaciguat, and inhibitors of RhoA ‐associated protein kinase Y27632 or p21‐activated protein kinase 1 IPA‐3 were tested by wire myography. Results: Caldesmon was expressed in all preglomerular vessels of mice and humans. In caldesmon +/− IAs of young mice , caldesmon protein was 50% less than in IAs of wild‐type mice . In IAs of old mice , caldesmon was less than in IAs of young mice and not significantly different between caldesmon +/− and wild‐type. Caldesmon mutation did not affect phenylephrine‐induced contraction or cinaciguat sensitivity but induced a rightward shift of Y27632 ‐induced relaxation in IAs of young and old mice and a reduction in IPA‐3– induced relaxation by 50% only in IAs of young mice . In human renal arteries, caldesmon expression negatively correlated with age and the presence of renal inflammation. In the inflammation group, a reduction in estimated glomerular filtration rate was detected. Conclusions: This study provides cumulative evidence that caldesmon is a marker of age and inflammation‐related changes in preglomerular vascular function. Our work supports the view that in the renal vasculature, caldesmon expression is age dependent and determines its sensitivity to the RhoA ‐associated protein kinase/p21‐activated protein kinase 1 regulatory pathway.

  • Open Access

    Angiotensin II type 1 receptor localizes at the blood–bile barrier in humans and pigs

    by Galyna Pryymachuk, Ehab El-Awaad, Nadin Piekarek, Uta Drebber, Alexandra C. Maul, Juergen Hescheler, Andreas Wodarz, Gabriele Pfitzer, Wolfram F. Neiss, Markus Pietsch, et al.

    Animal models and clinical studies suggest an influence of angiotensin II (AngII) on the pathogenesis of liver diseases via the renin–angiotensin system. AngII application increases portal blood pressure, reduces bile flow, and increases permeability of liver tight junctions. Establishing the subcellular localization of angiotensin II receptor type 1 (AT1R), the main AngII receptor, helps to understand the effects of AngII on the liver. We localized AT1R in situ in human and porcine liver and porcine gallbladder by immunohistochemistry. In order to do so, we characterized commercial anti-AT1R antibodies regarding their capability to recognize heterologous human AT1R in immunocytochemistry and on western blots, and to detect AT1R using overlap studies and AT1R-specific blocking peptides. In hepatocytes and canals of Hering, AT1R displayed a tram-track-like distribution, while in cholangiocytes AT1R appeared in a honeycomb-like pattern; i.e., in liver epithelia, AT1R showed an equivalent distribution to that in the apical junctional network, which seals bile canaliculi and bile ducts along the blood–bile barrier. In intrahepatic blood vessels, AT1R was most prominent in the tunica media. We confirmed AT1R localization in situ to the plasma membrane domain, particularly between tight and adherens junctions in both human and porcine hepatocytes, cholangiocytes, and gallbladder epithelial cells using different anti-AT1R antibodies. Localization of AT1R at the junctional complex could explain previously reported AngII effects and predestines AT1R as a transmitter of tight junction permeability.